145 related articles for article (PubMed ID: 31219232)
1. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
[TBL] [Abstract][Full Text] [Related]
2. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
3. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
[TBL] [Abstract][Full Text] [Related]
4. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
5. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
[TBL] [Abstract][Full Text] [Related]
6. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
7. Cell surface antigen CD109 is a novel member of the alpha(2) macroglobulin/C3, C4, C5 family of thioester-containing proteins.
Lin M; Sutherland DR; Horsfall W; Totty N; Yeo E; Nayar R; Wu XF; Schuh AC
Blood; 2002 Mar; 99(5):1683-91. PubMed ID: 11861284
[TBL] [Abstract][Full Text] [Related]
8. Epidermal hyperplasia and appendage abnormalities in mice lacking CD109.
Mii S; Murakumo Y; Asai N; Jijiwa M; Hagiwara S; Kato T; Asai M; Enomoto A; Ushida K; Sobue S; Ichihara M; Takahashi M
Am J Pathol; 2012 Oct; 181(4):1180-9. PubMed ID: 22846721
[TBL] [Abstract][Full Text] [Related]
9. The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.
Tanabe M; Hosokawa K; Nguyen MAT; Nakagawa N; Maruyama K; Tsuji N; Urushihara R; Espinoza L; Elbadry MI; Mohiuddin M; Katagiri T; Ono M; Fujiwara H; Chonabayashi K; Yoshida Y; Yamazaki H; Hirao A; Nakao S
Leukemia; 2022 Mar; 36(3):847-855. PubMed ID: 34743190
[TBL] [Abstract][Full Text] [Related]
10. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes.
Finnson KW; Tam BY; Liu K; Marcoux A; Lepage P; Roy S; Bizet AA; Philip A
FASEB J; 2006 Jul; 20(9):1525-7. PubMed ID: 16754747
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
[TBL] [Abstract][Full Text] [Related]
13. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
14. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
15. Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.
Hagikura M; Murakumo Y; Hasegawa M; Jijiwa M; Hagiwara S; Mii S; Hagikura S; Matsukawa Y; Yoshino Y; Hattori R; Wakai K; Nakamura S; Gotoh M; Takahashi M
Pathol Int; 2010 Nov; 60(11):735-43. PubMed ID: 20946523
[TBL] [Abstract][Full Text] [Related]
16. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
[TBL] [Abstract][Full Text] [Related]
17. Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling.
Mori N; Esaki N; Shimoyama Y; Shiraki Y; Asai N; Sakai T; Nishida Y; Takahashi M; Enomoto A; Mii S
Pathol Res Pract; 2023 May; 245():154443. PubMed ID: 37030166
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity.
Hagiwara S; Murakumo Y; Sato T; Shigetomi T; Mitsudo K; Tohnai I; Ueda M; Takahashi M
Cancer Sci; 2008 Oct; 99(10):1916-23. PubMed ID: 19016750
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD109 in human cancer.
Hashimoto M; Ichihara M; Watanabe T; Kawai K; Koshikawa K; Yuasa N; Takahashi T; Yatabe Y; Murakumo Y; Zhang JM; Nimura Y; Takahashi M
Oncogene; 2004 Apr; 23(20):3716-20. PubMed ID: 15116102
[TBL] [Abstract][Full Text] [Related]
20. CD109 and squamous cell carcinoma.
Qi R; Dong F; Liu Q; Murakumo Y; Liu J
J Transl Med; 2018 Apr; 16(1):88. PubMed ID: 29625613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]